103 related articles for article (PubMed ID: 2926241)
1. Characterization of a novel myeloma cell line, MM.1.
Goldman-Leikin RE; Salwen HR; Herst CV; Variakojis D; Bian ML; Le Beau MM; Selvanayagan P; Marder R; Anderson R; Weitzman S
J Lab Clin Med; 1989 Mar; 113(3):335-45. PubMed ID: 2926241
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2.
Nagai T; Ogura M; Morishita Y; Okumura M; Kato Y; Morishima Y; Hirabayashi N; Ohno R; Saito H
Int J Hematol; 1991 Apr; 54(2):141-9. PubMed ID: 1747447
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of two human myeloma cell lines secreting kappa light chains.
Eton O; Scheinberg DA; Houghton AN
Leukemia; 1989 Oct; 3(10):729-35. PubMed ID: 2506399
[TBL] [Abstract][Full Text] [Related]
4. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia.
Kubonishi I; Seto M; Shimamura T; Enzan H; Miyoshi I
Cancer; 1992 Sep; 70(6):1528-35. PubMed ID: 1516003
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia.
Otsuki T; Nakazawa N; Taniwaki M; Yamada O; Sakaguchi H; Wada H; Yawata Y; Ueki A
Int J Oncol; 1998 Mar; 12(3):545-52. PubMed ID: 9472091
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of genetic aberrations in human multiple myeloma cell lines and newly diagnosed MM by fluorescence in situ hybridization].
An G; Xie ZQ; Li CH; Li Q; Yi SH; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1505-10. PubMed ID: 21176360
[TBL] [Abstract][Full Text] [Related]
7. Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996).
Jernberg H; Nilsson K; Zech L; Lutz D; Nowotny H; Scheirer W
Blood; 1987 Jun; 69(6):1605-12. PubMed ID: 3580570
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell karyotype in multiple myeloma.
Gould J; Alexanian R; Goodacre A; Pathak S; Hecht B; Barlogie B
Blood; 1988 Feb; 71(2):453-6. PubMed ID: 3337907
[TBL] [Abstract][Full Text] [Related]
10. Establishment and biological characteristics of human multiple myeloma cell line CZ-1.
Hou J; Lin FY; Zhang B; Zhang LZ; Ding SQ
Chin Med J (Engl); 2004 Jan; 117(1):115-9. PubMed ID: 14733786
[TBL] [Abstract][Full Text] [Related]
11. Two distinct human myeloma cell lines originating from one patient with myeloma.
Katagiri S; Yonezawa T; Kuyama J; Kanayama Y; Nishida K; Abe T; Tamaki T; Ohnishi M; Tarui S
Int J Cancer; 1985 Aug; 36(2):241-6. PubMed ID: 3926660
[TBL] [Abstract][Full Text] [Related]
12. A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(q11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-Myc protein.
Iida S; Hanamura I; Suzuki T; Kamiya T; Kato M; Hayami Y; Miura K; Harada S; Tsuboi K; Wakita A; Akano Y; Taniwaki M; Nitta M; Ueda R
Int J Hematol; 2000 Jul; 72(1):85-91. PubMed ID: 10979215
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene.
Gazdar AF; Oie HK; Kirsch IR; Hollis GF
Blood; 1986 Jun; 67(6):1542-9. PubMed ID: 2423157
[TBL] [Abstract][Full Text] [Related]
14. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin.
Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K
Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285
[TBL] [Abstract][Full Text] [Related]
15. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
Chesi M; Kuehl WM; Bergsagel PL
Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.
Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG
Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357
[TBL] [Abstract][Full Text] [Related]
17. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
[TBL] [Abstract][Full Text] [Related]
18. Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation.
Zhang Y; Zhao H; He X; Zheng S; Wang T; Yan D; Sun J; Lu X; Wen J; Lau WY
Sci China Life Sci; 2012 Aug; 55(8):735-43. PubMed ID: 22932889
[TBL] [Abstract][Full Text] [Related]
19. [Establishment and biological characteristics of human multiple myeloma cell line CZ-1].
Hou J; Zhang B; Zhang L; Ding S
Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):509-13. PubMed ID: 12482345
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a permanent human IgA2/kappa myeloma cell line.
Lohmeyer J; Hadam M; Santoso S; Förster W; Schulz A; Pralle H
Br J Haematol; 1988 Jul; 69(3):335-43. PubMed ID: 3136791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
